<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bruin-Versteeg, S. de</title>
    <link>http://repub.eur.nl/res/aut/2850/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency (Article)</title>
      <link>http://repub.eur.nl/res/pub/15493/</link>
      <pubDate>2009-01-01T00:00:00Z</pubDate>
      <description>One of the severe combined immunodeficiencies (SCIDs), which is caused by a genetic defect in the signal transduction pathways involved in T-cell activation, is the ZAP70 deficiency. Mutations in ZAP70 lead to both abnormal thymic development and defective T-cell receptor (TCR) signaling of peripheral T-cells. In contrast to the lymphopenia in most SCID patients, ZAP70-deficient patients have lymphocytosis, despite the selective absence of CD8+ T-cells. The clinical presentation is usually before 2 years of age with typical findings of SCID. Here, we present three new ZAP70-deficient patients who vary in their clinical presentation. One of the ZAP70-deficient patients presented as a classical SCID, the second patient presented as a healthy looking wheezy infant, whereas the third patient came to clinical attention for the eczematous skin lesions simulating atopic dermatitis with eosinophilia and elevated immunoglobulin E (IgE), similar to the Omenn syndrome. This study illustrates that awareness of the clinical heterogeneity of ZAP70 deficiency is of utmost importance for making a fast and accurate diagnosis, which will contribute to the improvement of the adequate treatment of this severe immunodeficiency.</description>
    </item> <item>
      <title>Two patients with complete defects in interferon gamma receptor-dependent signaling (Article)</title>
      <link>http://repub.eur.nl/res/pub/35908/</link>
      <pubDate>2007-09-01T00:00:00Z</pubDate>
      <description>Unusual susceptibility to mycobacterial infections can be caused by deleterious mutations in genes that encode the interferon-γ receptor 1 chain. Such mutations hamper the activation of macrophages by a type 1 immune response and result in enhanced survival of intracellular pathogens. We here report two patients with unusual mycobacterial infections, both diagnosed with homozygous deleterious interferon-γ receptor 1 gene mutations. Patient 1 became ill after Bacillus Calmette-Guérin vaccination at the age of 9 months and died at the age of 18 months. She carried a homozygous C71Y mutation in the extracellular part of the mature interferon-γ receptor 1 protein, resulting in the lack of detectable protein expression and absence of interferon-γ dependent signaling. Patient 2 became ill at the age of 3 years, is still alive at 19 years of age, and has suffered from five successive infection episodes with atypical mycobacteria. A homozygous splice-site mutation in intron 3 was identified, resulting in the deletion of exon 3 at the mRNA level and consequently a truncated interferon-γ receptor 1 protein with absence of the transmembrane domain. Protein expression and interferon-γ dependent signaling were not detectable. </description>
    </item> <item>
      <title>Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow (Article)</title>
      <link>http://repub.eur.nl/res/pub/8235/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Severe combined immunodeficiency disease (SCID) can be immunologically
      classified by the absence or presence of T, B, and natural killer (NK)
      cells. About 30% of T(-)B(-)NK(+) SCID patients carry mutations in the
      recombination activating genes (RAG). Some T(-)B(-)NK(+) SCID patients
      without RAG gene mutations are sensitive to ionizing radiation, and
      several of these radiosensitive (RS) SCID patients were recently shown to
      have large deletions or truncation mutations in the Artemis gene, implying
      a role for Artemis in DNA double-strand break (dsb) repair. We identified
      5 RS-SCID patients without RAG gene mutations, 4 of them with Artemis gene
      mutations. One patient had a large genomic deletion, but the other 3
      patients carried simple missense mutations in conserved amino acid
      residues in the SNM1 homology domain of the Artemis protein.
      Extrachromosomal V(D)J recombination assays showed normal and precise
      signal joint formation, but inefficient coding joint formation in
      fibroblasts of these patients, which could be complemented by the
      wild-type Artemis gene. The cells containing the missense mutations in the
      SNM1 homology domain had the same recombination phenotype as the cells
      with the large deletion, indicating that these amino acid residues are
      indispensable for Artemis function. Immunogenotyping and immunophenotyping
      of bone marrow samples of 2 RS-SCID patients showed the absence of
      complete V(H)-J(H) gene rearrangements and consequently a complete B-cell
      differentiation arrest at the pre-B-cell receptor checkpoint-that is, at
      the transition from CyIgmu(-) pre-B-I cells to CyIgmu(+) pre-B-II cells.
      The completeness of this arrest illustrates the importance of Artemis at
      this stage of lymphoid differentiation.</description>
    </item> <item>
      <title>The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins (Article)</title>
      <link>http://repub.eur.nl/res/pub/8222/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>The protein products of the recombination activating genes (RAG1 and RAG2)
      initiate the formation of immunoglobulin (Ig) and T-cell receptors, which
      are essential for B- and T-cell development, respectively. Mutations in
      the RAG genes result in severe combined immunodeficiency disease (SCID),
      generally characterized by the absence of mature B and T lymphocytes, but
      presence of natural killer (NK) cells. Biochemically, mutations in the RAG
      genes result either in nonfunctional proteins or in proteins with partial
      recombination activity. The mutated RAG genes of 9 patients from 7
      families were analyzed for their recombination activity using
      extrachromosomal recombination substrates, rearrangement of endogenous Ig
      loci in RAG gene-transfected nonlymphoid cells, or the presence of Ig gene
      rearrangements in bone marrow (BM). Recombination activity was virtually
      absent in all 6 patients with mutations in the RAG core domains, but
      partial activity was present in the other 3 RAG-deficient patients, 2 of
      them having Omenn syndrome with oligoclonal T lymphocytes. Using 4-color
      flow cytometry, we could define the exact stage at which B-cell
      differentiation was arrested in the BM of 5 RAG-deficient SCID patients.
      In 4 of 5 patients, the absence of recombination activity was associated
      with a complete B-cell differentiation arrest at the transition from
      cytoplasmic (Cy) Igmu(-) pre-B-I cells to CyIgmu(+) pre-B-II cells.
      However, the fifth patient showed low frequencies of precursor B cells
      with CyIgmu and surface membrane IgM, in line with the partial
      recombination activity of the patient's mutated RAG gene and the detection
      of in-frame Ig gene rearrangements in BM.</description>
    </item> <item>
      <title>Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children (Article)</title>
      <link>http://repub.eur.nl/res/pub/9829/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>X-linked agammaglobulinemia (XLA) is characterized by a severe B-cell
      deficiency, resulting from a differentiation arrest in the bone marrow
      (BM). Because XLA is clinically and immunologically heterogeneous, we
      investigated whether the B-cell differentiation arrest in BM of XLA
      patients is heterogeneous as well. First, we analyzed BM samples from 19
      healthy children by flow cytometry. This resulted in a normal B-cell
      differentiation model with eight consecutive stages. Subsequently, we
      analyzed BM samples from nine XLA patients. Eight patients had amino acid
      substitutions in the Bruton's tyrosine kinase (BTK) domain or premature
      stop codons, resulting in the absence of functional BTK proteins. In seven
      of these eight patients a major differentiation arrest was observed at the
      transition between cytoplasmic Ig(mu-) pre-B-I cells and cytoplasmic
      Ig(mu+) pre-B-II cells, consistent with a role for BTK in pre-B-cell
      receptor signaling. However, one patient exhibited a very early arrest at
      the transition between pro-B cells and pre-B-I cells, which could not be
      explained by a different nature of the BTK mutation. We conclude that the
      absence of functional BTK proteins generally leads to an almost complete
      arrest of B-cell development at the pre-B-I to pre-B-II transition. The
      ninth XLA patient had a splice site mutation associated with the presence
      of low levels of wild-type BTK mRNA. His BM showed an almost normal
      composition of the precursor B-cell compartment, suggesting that low
      levels of BTK can rescue the pre-B-cell receptor signaling defect, but do
      not lead to sufficient numbers of mature B lymphocytes in the peripheral
      blood.</description>
    </item> <item>
      <title>Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus (Article)</title>
      <link>http://repub.eur.nl/res/pub/9583/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Regulation of allelic and isotypic exclusion of human immunoglobulin (Ig)
      light-chain genes was studied in 113 chronic B-cell leukemias as a
      "single-cell" model that allowed complete analysis of each light chain
      allele. Our data show that monospecific Ig light chain expression is in
      about 90% of cases determined by ordered recombination: Igkappa gene (IGK)
      rearrangements, followed by IGK deletions and Iglambda gene (IGL)
      rearrangements, resulting in the presence of only one functional Ig light
      chain rearrangement. In about 10% (10 cases), 2 functional Ig light chain
      rearrangements (IGK/IGL or IGL/IGL, but not IGK/IGK) were identified. This
      might be explained by the fact that regulation of the ordered
      recombination process is not fully strict, particularly when the IGL locus
      is involved. Unfavorable somatic mutations followed by receptor editing
      might have contributed to this finding. Eight of these 10 cases indeed
      contained somatic mutations. In cases with 2 functional Ig light chain
      rearrangements, both alleles were transcribed, but monospecific Ig
      expression was still maintained. This suggests that in these cases
      allelelic exclusion is not regulated at the messenger RNA level but either
      at the level of translation or protein stability or via preferential
      pairing of Ig light and Ig heavy chains. Nevertheless, ordered
      rearrangement processes are the main determinant for monospecific Ig light
      chain expression.</description>
    </item> <item>
      <title>Longitudinal survey of lymphocyte subpopulations in the first year of life (Article)</title>
      <link>http://repub.eur.nl/res/pub/9310/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Age-matched reference values for lymphocyte subpopulations are generally
          obtained via cross-sectional studies, whereas patients are followed
          longitudinally. We performed a detailed longitudinal analysis of the
          changes in lymphocyte subpopulations in a group of 11 healthy infants
          followed from birth up to 1 y of age, with special attention for early
          developmental markers, markers of maturation, and markers of activation.
          We found that T and B lymphocytes increased at 1 and 6 wk of age,
          respectively. In contrast, NK cells showed a sharp decline directly after
          birth, suggesting that they are more important during pregnancy than
          thereafter. CD45RA+--mainly CD4+--naive T lymphocytes were high at birth,
          and increased further during the first year of life; they form a large
          expanding pool of cells, ready for participation in primary immune
          responses. The absolute counts of CD45RO+ memory T lymphocytes were
          similar in infants and adults, albeit with a lower level of expression of
          CD45RO on infant T lymphocytes. Almost all infant T lymphocytes expressed
          CD38 throughout the first year of life. The abundant expression of CD38 on
          an infant's T lymphocytes might be related to a greater metabolic need of
          the large population of naive untriggered cells that are continually
          involved in primary immune responses during the first year of life. The
          high B lymphocyte counts in infants mainly concerned CD38+ B lymphocytes
          throughout the first year of life. Also, the relative frequencies of CD1c+
          and CD5+ B lymphocytes were higher throughout the first year of life than
          in adults. Therefore, CD1c, CD5, and CD38 could be markers of untriggered
          B lymphocytes. In conclusion, our longitudinal survey of T and B
          lymphocytes, NK cells, and their subpopulations during the first year of
          life helps to complete the picture of lymphocyte development in infants.
          This information contributes to the correct interpretation of data from
          infants with possible immune disorders.</description>
    </item> <item>
      <title>Correction for erythroid cell contamination in microassay for immunophenotyping of neonatal lymphocytes (Article)</title>
      <link>http://repub.eur.nl/res/pub/9083/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Immunophenotyping of blood lymphocyte subpopulations in neonates and young
          infants is hampered by the limited amount of blood that can be collected.
          Contamination of the flow cytometric "lympho-gate" by normoblasts and
          analysed erythrocytes, and therefore the underestimation of the relative
          frequencies of lymphocyte subpopulations, interferes with the precise
          calculation of absolute counts. A microassay was developed by adapting the
          lysed whole blood technique. Triple immunostaining in a single antibody
          staining step was used to reduce washing steps and cell loss. Introduction
          of a triple staining for CD71 (expressed by erythroid precursors),
          glycophorin A (GpA, expressed by all erythroid cells), and CD45 (expressed
          by all leucocytes) permitted the relative frequencies of normoblasts
          (CD71(+)/GpA+/CD45(-) population) and unlysed erythrocytes
          (CD71(-)/GpA+/CD45(-) population)to be identified and measured within the
          "lympho-gate" of neonatal cord blood samples. Particularly high
          frequencies were found (median: 31%) in cord blood samples from preterm
          neonates. These erythroid cells disappear rapidly by 1 week of age The
          relative frequencies of erythroid cells can be used to calculate correct
          lymphocyte subpopulation values. Using only 0.5-0.8 ml of blood, this
          micro- assay would also be suitable for rapid prenatal immunodiagnosis of
          congenital immunodeficiencies.</description>
    </item>
  </channel>
</rss>